Cerus
CERS
#7696
Rank
โ‚น32.61 B
Marketcap
โ‚น169.79
Share price
1.61%
Change (1 day)
11.79%
Change (1 year)

Revenue for Cerus (CERS)

Revenue in 2025 (TTM): โ‚น17.23 Billion

According to Cerus's latest financial reports the company's current revenue (TTM ) is โ‚น17.89 Billion. In 2024 the company made a revenue of โ‚น15.46 Billion an increase over the revenue in the year 2023 that were of โ‚น13.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cerus from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น17.23 B11.42%
2024 โ‚น15.46 B18.8%
2023 โ‚น13.01 B-2.92%
2022 โ‚น13.40 B37.67%
2021 โ‚น9.73 B44.89%
2020 โ‚น6.72 B26.28%
2019 โ‚น5.32 B24.99%
2018 โ‚น4.25 B53.09%
2017 โ‚น2.78 B10.1%
2016 โ‚น2.52 B11.1%
2015 โ‚น2.27 B-1.46%
2014 โ‚น2.30 B-5.8%
2013 โ‚น2.45 B22.25%
2012 โ‚น2.00 B14.65%
2011 โ‚น1.74 B68.81%
2010 โ‚น1.03 B24.11%
2009 โ‚น0.83 B5.16%
2008 โ‚น0.79 B92.18%
2007 โ‚น0.41 B-73.8%
2006 โ‚น1.57 B43.69%
2005 โ‚น1.09 B82.04%
2004 โ‚น0.60 B36.91%
2003 โ‚น0.44 B8.08%
2002 โ‚น0.40 B86.06%
2001 โ‚น0.21 B153.3%
2000 โ‚น86.38 M-14.86%
1999 โ‚น0.10 B-17.71%
1998 โ‚น0.12 B-54.53%
1997 โ‚น0.27 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Haemonetics
HAE
โ‚น119.28 B 566.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.08 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚น1.738 T 9,614.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚น3.48 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA